Contribution of the renin–angiotensin system to subsensitivity of soluble guanylyl cyclase in TGR(mREN2)27 rats

Ackermann, 1997 Bachmann, 1992, Transgenic rats carrying the mouse renin gene-morphological characterization of a low-renin hypertension model, Kidney Int., 41, 24, 10.1038/ki.1992.4 Bauersachs, 1999, Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression, Circulation, 100, 292, 10.1161/01.CIR.100.3.292 Behrends, 2000, Expression of nitric oxide-sensitive guanylyl cyclase subunits in human corpus cavernosum, Biochem. Pharmacol., 59, 713, 10.1016/S0006-2952(99)00381-0 Brandes, 2000, Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice, Hypertension, 35, 231, 10.1161/01.HYP.35.1.231 Busse, 1998, Pulsatile stretch and shear stress: physical stimuli determining the production of endothelium-derived relaxing factors, J. Vasc. Res., 35, 73, 10.1159/000025568 Chen, 2000, Loss of expression of the β subunit of soluble guanylyl cyclase prevents nitric oxide-mediated inhibition of DNA synthesis in smooth muscle cells of old rats, Circ. Res., 86, 520, 10.1161/01.RES.86.5.520 Dominiczak, 1995, Nitric oxide and its putative role in hypertension, Hypertension, 25, 1202, 10.1161/01.HYP.25.6.1202 Filippov, 1997, Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells, J. Clin. Invest., 100, 942, 10.1172/JCI119610 Griendling, 1994, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells, Circ. Res., 74, 1141, 10.1161/01.RES.74.6.1141 Gupta, 1997, The β2 subunit inhibits stimulation of the α1/β1 form of soluble guanylyl cyclase by nitric oxide, J. Clin. Invest., 100, 1488, 10.1172/JCI119670 Klöß, 2000, Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase, Hypertension, 35, 43, 10.1161/01.HYP.35.1.43 Kojda, 1998, Alterations of the vascular and the myocardial guanylate cyclase/cGMP-system induced by long-term hypertension in rats, Pharm. Acta Helv., 73, 27, 10.1016/S0031-6865(97)00044-7 Lee, 1996, Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27, Am. J. Physiol., 270, E919 Lemmer, 1993, Circadian blood pressure variation in transgenic hypertensive rats, Hypertension, 22, 97, 10.1161/01.HYP.22.1.97 Mattes, 1991, Pharmfit — a nonlinear fitting program for pharmacology, Chronobiol. Int., 8, 460, 10.3109/07420529109059182 McIntyre, 1999, Endothelial function in hypertension, Hypertension, 34, 539, 10.1161/01.HYP.34.4.539 Minor, 1990, Diet-induced atherosklerosis increases the release of nitrogen oxides from rabbit aorta, J. Clin. Invest., 86, 2109, 10.1172/JCI114949 Morley, 1993, Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators, J. Cardiovasc. Pharmacol., 22, 3, 10.1097/00005344-199300221-00003 Ohta, 1996, Contribution of local renin–angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR(mRen2)27 transgenic rats, Circulation, 94, 785, 10.1161/01.CIR.94.4.785 Pinto, 1997, Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats, J. Mol. Med., 75, 371, 10.1007/s001090050123 Saito, 1996, Angiotensin II activates endothelial constitutive nitric oxide synthase via AT1 receptors, Hypertens. Res., 19, 201, 10.1291/hypres.19.201 Sander, 1994, Role of adrenal renin in the regulation of adrenal steroidogenesis by corticotropin, Proc. Natl. Acad. Sci. U. S. A., 91, 148, 10.1073/pnas.91.1.148 Simchon, 1996, Impaired renal vasodilatation and urinary cGMP excretion in Dahl salt-sensitive rats, Hypertension, 27, 653, 10.1161/01.HYP.27.3.653 Stone, 1994, Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states, Biochemistry, 33, 5636, 10.1021/bi00184a036 Struijker-Boudier, 1996, Disproportional arterial hypertrophy in hypertensive mRen-2 transgenic rats, Hypertension, 28, 779, 10.1161/01.HYP.28.5.779 Vaziri, 1999, cGMP-mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide, Hypertension, 34, 1237, 10.1161/01.HYP.34.6.1237 Véniant, 1995, Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mREN2)27 rats, Am. J. Hypertens., 8, 1167, 10.1016/0895-7061(95)00254-5 Villarreal, 1995, Myocardial remodeling in hypertensive Ren-2 transgenic rats, Hypertension, 25, 98, 10.1161/01.HYP.25.1.98 Wattanapitayakul, 2000, Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders, FASEB J., 14, 271, 10.1096/fasebj.14.2.271 Witte, 1995, Contribution of the nitric oxide–guanylyl cyclase system to circadian regulation of blood pressure in normotensive Wistar–Kyoto rats, Cardiovasc. Res., 30, 682, 10.1016/0008-6363(95)00072-0 Witte, 1998, Signal transduction in cardiac and vascular tissue from normotensive and transgenic hypertensive TGR(mREN2)27 rats, Eur. J. Pharmacol., 341, 337, 10.1016/S0014-2999(97)01486-6 Witte, 1999, Cardiovascular risk, renal hypertensive damage, and effects of amlodipine treatment in transgenic TGR(mREN2)27 rats, Gen. Pharmacol., 33, 423, 10.1016/S0306-3623(99)00037-3